0% found this document useful (0 votes)
10 views

医用输液,输血,注射器检测方法

Uploaded by

qq1020451412
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
10 views

医用输液,输血,注射器检测方法

Uploaded by

qq1020451412
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 7

GB/T 14233.

2-2005

ICS 11.040.20

C 31

NATIONAL STANDARD OF THE PEOPLE’S REPUBLIC


OF CHINA

中华人民共和国国家标准
GB/T 14233.2–2005

Replace GB/T 14233.2–1993

Test methods for infusion, transfusion, injection

equipment for medical use-Part 2: Biological test methods

医用输液、输血、注射器具检验方法

第 2 部分:生物学实验方法

Issued on November 17, 2005 Implemented on May 01, 2006

Issued by General Administration of Quality Supervision, Inspection and


Quarantine of the People’s Republic of China

Standardization Administration of the People’s Republic of China

1
GB/T 14233.2-2005

Contents
Foreword ........................................................................................................................................1
Introduction ...................................................................................................................................2
1 Scope.......................................................................................................................................3
2 Normative reference ............................................................................................................3
3 Sterility test............................................................................................................................4
4 Bacterial endotoxin test .....................................................................................................6
5 Pyrogen test ..........................................................................................................................9
6 Acute systemic toxicity ....................................................................................................11
7 Hemolytic test .....................................................................................................................14
8 Cytotoxicity test..................................................................................................................16
9 Sensitization test (with the maximum dose method) ...............................................21
10 Intradermal reaction test ..............................................................................................22
Annex A (Informative) Subacute (Subchronic) Systemic Toxicity Test.......................28
A.1 Objective .......................................................................................................................28
A.2 Reagent .........................................................................................................................28
A.3 Main equipment and devices ...................................................................................28
A.4 Preparations before test............................................................................................28
A.5 Testing methods..........................................................................................................30
Annex B (Informative) Test of Interaction with Blood (instrument) ..............................35
B.1 General Principle ........................................................................................................35
B.2 Test of Internal Venous Thrombosis......................................................................35
B.3 Whole blood clotting time.........................................................................................37
B.4 Partial thromboplastin time (ptt) test.....................................................................39
B.5 Extracorporal spontaneous platelet aggregation test ......................................41
B.6 Platelet Adhesion Test ...............................................................................................43
B.7 Complement Activation Test ....................................................................................45
Annex C (Informative) Preparation of Common Solutions and Nutrient Solution of
Cell Culture ..................................................................................................................................48
C.1 Balanced Salt Solution (BBS) ..................................................................................48
C.2 Digestive Juice ............................................................................................................49
C.3 Methyl Thiazolyl Tetrazolium (MTT) Staining Fluid ............................................49
C.4 RPMI 1640 Cell Nutrient Solution............................................................................49

2
GB/T 14233.2-2005

Foreword
GB/T 14233 Test methods for infusion, transfusion, injection equipment for medical use

consist of following two parts:

— Part 1: Chemical analysis methods;

— Part 2: Biological test methods.

This is part 2 of GB/T 14233. This part will replace GB/T 14233.2-1993 Infusion,

transfusion, injection equipment for medical use-Part 2: Biological test methods. This

revision for three testing such as sterile, pyrogen and bacterial endotoxin and direct

reference to application articles in Chinese Pharmacopoeia II, so as to keep pace with

latest revision version of Chinese Pharmacopoeia; refer to GB/T 16886 Biological

evaluation of medical devices, revised the test methods of cytotoxicity; sensitization,

intradermal reaction and implantation test direct refer to GB/T 16886 Biological evaluation

of medical devices; added interactional test methods for subacute (subchronic) general

toxicity sanguis (apparatus), canceled product index of pass.

Annex A, B and C of this part are informative annex.

This part is proposed by State Food and Drug Administration (NADFC).

This part is under the jurisdiction of National Technical Committee on Medical Syringes of

Standardization Administration of China

The responsible drafting organizations are Jinan MDSIN Quality Inspection Center of

NADFC and Tianjin Medical Biomaterials Testing and Research Center.

The chief drafting staff of this standard includes Shao Hua, Zhu Xuetao, Liu Xin, Huang

Jingchun, Wang Xin, Zhu Junmei, Wang Kelei and Hao Shubin.

This part was issued for the first time on March, 1993.

1
GB/T 14233.2-2005

Introduction
Biological test methods given in this part are based on basic principles of GB/T 16886.1

Biological Evaluation of Medical Equipment Part 1: Evaluation and Test, and established

especially for needs of biological evaluation of infusion, transfusion and injection

equipment for medical use. Based on proper test methodology principles and test

procedures specified in GB/T 16886 Biological Evaluation of Medical Equipment and

Chinese Pharmacopoeia (second edition), this revision is made according to the

characteristics of infusion, transfusion, and injection equipment for medical use, therefore,

this part is equal with methods of GB/T 16886 and China Pharmacopoeia in methodology

and applies to the method standards measuring biological performance of infusion,

transfusion, and injection equipment for medical use..

This revision makes direct reference to applicable parts in China Pharmacopoeia for

sterility, pyrogen and bacterial endotoxin tests without indications of the year numbers of

the pharmacopoeia in order to keep pace with the latest revision of China Pharmacopoeia,

details the test projects that have no specific steps provided in GB/T 16886, such as cell

toxicity, acute general toxicity, sub-acute (sub-chronic) general toxicity and blood

(equipment) reciprocity reaction tests and directly refers to applicable parts in GB/T 16886

for stimulation, sensitization and implantation tests that give detailed test steps in GB/T

16886.

As a method standard for tests, this revision has canceled the index of qualified products

in the text, but a current general index for identification is provided in the note for

reference. Appropriate qualification indices should be provided in accordance with the

characteristics of products when this part is quoted by related product standards.

2
GB/T 14233.2-2005

Test Methods for Infusion, Transfusion, Injection Equipment

for Medical Use

Part 2:Biological Test Methods


1 Scope

This part of GB/T 14233 specifies test methods of infusion, transfusion, injection

equipment for medical use.

This part applies to infusion, transfusion, injection equipment for medical use.

2 Normative reference

The articles contained in the following documents have become this part of GB/T 14233

when they are quoted herein. For the dated documents so quoted, all the modifications

(excluding corrections) or revisions made thereafter shall not be applicable to this

Standard. For the undated documents so quoted, the latest editions shall be applicable to

this Standard.

GB/T 16886.1 Biological Evaluation of Medical Equipment Part 1: Evaluation and Test

(GB/T 16886.1-2001, idt ISO 10993-1:1997)

GB/T 16886.4 Biological Evaluation of Medical Equipment Part 4: Blood Reciprocity

Reaction Test Selection (GB/T 16886.4-2003, ISO 10993-4:2000, IDT)

GB/T 16886.5 Biological Evaluation of Medical Equipment Part 5: In Vitro Cell Toxicity

Test (GB/T 16886.5-2003, ISO 10993-5:1999, IDT)

GB/T 16886.6 Biological Evaluation of Medical Equipment Part 6: Post-Implantation Local

Response Test (GB/T 16886.6-1997, idt ISO 10993-6:1996)

GB/T 16886.10 Biological Evaluation of Medical Equipment Part 10: Stimulation and

Delayed Type Hypersensitivity Test (GB/T 16886.10-2005, ISO 10993-10:2002, IDT)

GB/T 16886.11 Biological Evaluation of Medical Equipment Part 11: Acute General

Toxicity Test (GB/T 16886.11-1997, idt ISO 10993-11: 1993)

GB/T 16886.12 Biological Evaluation of Medical Equipment Part 12: Sample Preparation

and Reference (GB/T 16886.12-2005, ISO 10993-12: 2002, IDT)

China Pharmacopeia Second edition

3
GB/T 14233.2-2005

3 Sterility test
3.1 Objective

This test is to inoculate medical equipment or its extract into the culture medium with an

intention to test whether the samples would be contaminated by bacteria and funguses.

3.2 Reagent

Sterile sodium chloride solution with mass concentration of 9 g/L and other dilution and

washing liquid that meet the requirements of China Pharmacopoeia.

3.3 Main equipment

Clean bench, optical microscopy, constant temperature incubator, thermostat water bath

box, pressure steam sterilizer and electrically heated drying cabinet.

3.4 Preparations before test

3.4.1 Equipment sterilization

All equipment in contact with the test solution should be sterilized reliably in a 12l℃

pressure steam sterilizer for 30 minutes or in a 160℃ electrically heated drying cabinet for

2 hours.

3.4.2 Requirements for sterile rooms

3.4.2.1 Bench boards or clean benches in sterile rooms shall locally meet the

requirements of Class 100 cleanliness with unidirectional air flow part. After the sterile

room is disinfected, the number of bacteria colonies shall be checked by the way as

follows: take a petri dish with a diameter about 90 mm and inject it with about 20mL of

melted nutrient agar with aseptic technique. If it proves sterile after cultivation for 48 hours

at 30℃~35℃, place another 3 dishes on the bench board or clean bench at the average

position and open their covers, then cover the dishes and cultivate them in the

environment of 30℃~35℃ for 48 hours after exposure 30min and take them out to check.

The number of bacterial colonies growing in each of 3 dishes shall not be more than 1 on

average.

3.4.2.2 In sterility test, colony forming units in the air shall be checked by the way as

above. Cultivation as above with opening dish covers at the beginning and covering at the

end of the test shall comply with the said requirements.

3.5 Culture medium

4
北京文心雕语翻译有限公司
Beijing Lancarver Translation Inc.

完整版本请在线下单
或咨询:
TEL: 400-678-1309

QQ: 19315219

Email:[email protected]
http://www.lancarver.com

对公账户:
单位名称:北京文心雕语翻译有限公司

开 户 行:中国工商银行北京清河镇支行

账 号:0200 1486 0900 0006 131

支付宝账户:[email protected]

注: 付款成功后,请预留电邮,完整版本将在一个工作日内通过电子 PDF 或

Word 形式发送至您的预留邮箱,如需索取发票,下单成功后的三个工作日内安

排开具并寄出,预祝合作愉快!

You might also like